Subscribers - Log in to view the full kaboodle!


Our data - an introduction

Access to our data hub is probably one of the most valuable benefits of subscribing.

The powerful tools on there let you view and manipulate national prescribing data to:

  • benchmark what you are prescribing and spending against peers

  • identify priority areas

  • see the potential savings of making changes

  • see the cost of missed opportunities


Click the sliders below to read more about each of the tools:

 The Primary Care Scorecard 

The Primary Care Scorecard is the nerve centre for all of our strategic prescribing projects. The scorecard is directly aligned to our projects, and monitors changing activity at a CCG level, as we update it each month.

This resource is the first place to go before delving deeper into our data. Below is an outline of the scorecard's key features:

  • Summary Report - offering key information from all of the following tabs in one place for your CCG. As is the case throughout the document you can filter by YTD, last 3m or individual months within the FY.
  • Achievement - Compares CCGs across the partnership, grouped by Area Team, against all of our 50+ project indicators.
  • Monthly Progress - Mapping your CCG's monthly progress against the project indicators. See what's improving and what's not in your patch.
  • Ranking - Looks at how you compare, and rank, against the 211 CCGs nationally, your 10 'cluster' CCGs (most like you), and within the PrescQIPP Community. We also provide the Range within these groups.
  • Avoidance (to Target & 100%) - The cost avoidance each subscribed CCG could achieve within a 12 month period. Custom parameters to reflect recent activity.
  • Missed Opportunity (to Target & 100%) - The cost avoidance you could have achieved if the switch had been made - useful information for business cases.
  • Supporting info - including ePACT tags & tag listing and methodology - updated monthly, so you can replicate these projects at a practice level.

 The Quality Scorecard 

The quality scorecard brings together prescribing indicators which focus on appropriate prescribing,  medicines safety and medicines optimisation issues. National prescribing indicators have been included and there are a few other indicators which we thought would be useful.

There are no savings calculations on the quality scorecard and as with the primary care scorecard RAG ratings are based on the top 10% or 20% nationally to the national median.

 The DROP-List Scorecard 

Drugs to Review for Optimised Prescribing is one of our most popular project areas and we now have a scorecard to support it. For more information about the DROP-List please visit the DROP-List page.

 'Snapshots' for key prescribing areas 

For a number of key (really important or particularly complex) we produce 'snapshots' which are mini-scorecards dedicated to that area. These documents often provide more detailed information, or 'deep dive' down to a further level than we would within the Primary Care Scorecard.

Our current Snapshots include:

  • Specials Order Products Snapshot
  • Nutrition Snapshot
  • Continence Snapshot
  • Stoma Snapshot

All of these are updated regularly (most monthly), and wherever possible we also provide interactive maps on our Data Hub.

 Data packs to support each PrescQIPP Bulletin & Toolkit 



With each and every bulletin we release, we produce a data pack covering all of our subscribers. This provides a ready reckoner for prescribing teams, to identify where their organisation sits, and whether the project is a priority.

Within a typical data pack, you will expect to find:

  • A table covering all subscribers, grouped by area team, showing activity, total spend and per 1,000 patients. If the project is financially oriented, it will also include cost avoidance to target and 'best' (the highest performing CCG area).
  • Charts illustrating activity and cost - often totalled and per 1,000 patients, compared to national.
  • An Atlas of Variation style map showing activity across our subscribers.

Once published, data packs are updated every 6 months to include new subscribers and re-inform decision making.

 Financial Growth Reports (incl. Cat M) 


These reports come as a duo of delightfully detailed deliverables:

  • Summary Growth Report - detailing the year on year changes in both item, spend for all of our CCGs. Also includes a range of charts at CCG and AT level.
  • Deep Dive Growth Report - allowing you to select your CCG, and view the following:
    • Level 1 - BNF Chapter Level changes in spend and items.
    • Level 2 - Going down to section & chemical level within the selected BNF chapter. 
    • Top 100 - Showing the Top 100 chemicals in terms of Actual Growth in cost, and compared to national. 
  • Category M Growth Report - detailing increased costs relating to category M price changes.

 PrescQIPP Priorities Report 

 The Priorities Report brings together headline information from across our three scorecards (primary, DROP and quality) in a simple and accessible format. The report allows filtering of projects to support reporting within CCGs and CSUs.

binocs Specials Tariff Watch 

 The quarterly Specials Tariff Watch is designed to help prescribers navigate the changes in Part VIIIB of the drug tariff to facilitate cost-effective prescribing. It also includes the top ten list of potential highest savings. The document is based on, and replaces, work by Anne Fowler of NHS Lancashire (with thanks!).

sheild Primary Care Rebates Monitoring System 

PrescQIPP is now the country's largest provider of governance around Primary Care Rebates, and was amongst the very first.

In that time we've seen the landscape change dramatically around such schemes. Whilst there is still much uncertainty around the sustainability and place of rebates within primary care, statements such as the one from the ABPI in late 2013 have significantly increased activity.

Whilst PrescQIPP neither formally solicits nor endorses primary care rebates, we recognise that as activity continues at a local level, efforts should be made to provide governance and reduce the administrative burden. Tens of assessments from our Pharmaceutical Industry Scheme Governance Review Board can be found in the Rebates Section, and we have also produced a system to help CCGs scope the financial elements of schemes, and also track/validate financial claims. 



Below is just an example, however for all of the scorecard and snapshots areas we provide interactive maps to compare against CCGs across the country. The image below provides a fictitious example.